VLS Tirzepatide 20mg Pen
VLS Tirzepatide 20 mg prefilled pen—dual GIP/GLP-1 receptor agonist for managing type 2 diabetes and supporting weight loss with convenient weekly dosing.
£140.00
Tirzepatide 20mg Pen is a convenient, pre-filled injectable device designed to help manage type 2 diabetes and support weight loss. It combines the benefits of two powerful GLP-1 and GIP receptor agonists, improving blood sugar control and promoting weight management.
Brand: Generic Pharmaceutical
Dosage: 20mg pre-filled pen
Administration: Injectable
Common Usages: Used for type 2 diabetes management and weight loss.
Half-Life: Approximately 1 week.
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |
Related Products
Wegovy is a prescription weight loss injection that contains the active ingredient semaglutide.
- Once a week self-injection pen.
- Helps support weight loss by reducing appetite and making you feel fuller.
- Lose up to 17% of your starting weight.
Saxenda is a daily injection that helps you lose weight by making you feel fuller from less food. This makes losing weight easier when combined with a healthy diet and exercise plan.
Medication Features
-
- Once-weekly injection
- Weight loss injection by Eli Lilly
- Active ingredient: Tirzepatide
- Trials show ~20% body weight loss
- Available equivalent: Wegovy
Mounjaro is a once-weekly weight loss injection containing Tirzepatide and is now licensed for weight loss in the UK. It comes in pre-filled pens that contain 4 doses of Mounjaro and is injected ONCE weekly under the skin. Mounjaro has been clinically proven to achieve ~20% body weight loss or more and is used for Weight Management (weight loss and weight maintenance) and Type 2 diabetes.
Each pack of Mounjaro contains 4 x weekly doses plus needles
Take control of your weight loss journey your own way with Nevolat, the daily weight loss injection pen:
- Average weight loss of 8% over 56 weeks
- Reduces appetite and food cravings
- Generic weight loss treatment, making it cheaper than branded medication
Rybelsus is a once-daily tablet containing Semaglutide. It is licensed for type 2 diabetes and can be prescribed off-label for weight loss for those who prefer to take tablets instead of injections.
Ozempic is a once-weekly Semaglutide injection licensed for Type 2 diabetes.
Ozempic is an injection which contains the active ingredient semaglutide. Semaglutide is an effective weight loss treatment. This is the brand name “Wegovy” in the UK.
Each pack of Ozempic contains 4 x weekly doses.
Xenical 120mg Capsules
Xenical contains the active ingredient Orlistat. Xenical works by blocking 1/3rd of the fat you eat from being absorbed.
Xenical can be used by patients who have a BMI greater than 30 (or 28 if suffering from other weight related conditions such as high blood pressure or diabetes) and along with a low-calorie balanced diet, can be a safe and effective way to help with reaching your weight loss goals.
Synedica Retatrutide® Injection Pen Kit is the world’s most advanced weight loss solution. Retatrutide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of the GLP-1, GIP and glucagon receptors, which are natural hormones that makes humans feel full from eating much smaller portions of food.
The Synedica Retatrutide® 40mg Injection Pen Kit contains 1 pen, 12 disposable needles and an instruction booklet.
Each pen has 40mg which can be delivered across 4 full doses of 10mg, or in increments of 2.5mg, 5mg, 7.5mg or 10mg.
Recommended dosage is 2.5mg for the first 4 weeks, then 5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 7.5mg or 10mg if necessary.
Always consult your doctor, nurse or pharmacist before using any new medication.
Synedica Retatrutide® 40mg Injection Pen Kit is available at selected pharmacies across Germany, and potentially free for German citizens who qualify under Gesetzliche Krankenversicherung.
Semaglutide Pen
VLS Semaglutide 5 mg prefilled pen for convenient weekly dosing—supports weight management and blood sugar control with GLP-1 receptor agonist action.
*For research purposes only
VLS Retatrutide 20 mg prefilled pen – a triple-agonist targeting GIP, GLP-1, and glucagon receptors for potent appetite suppression, metabolic support, and weight management.
*For research purposes only
Synedica Tirzepatide® Injection Pen Kit is the world’s most advanced weight loss solution. Commonly known as “Mounjaro,” tirzepatide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of the GLP-1 and GIP receptors, which are natural hormones that makes humans feel full from eating much smaller portions of food.
The Synedica Tirzepatide® 40mg Injection Pen Kit contains 1 pen, 12 disposable needles and an instruction booklet.
Each pen has 40mg which can be delivered across 4 full doses of 10mg, or in increments of 2.5mg, 5mg, 7.5mg or 10mg.
Recommended dosage is 2.5mg for the first 4 weeks, then 5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 7.5mg or 10mg if necessary.
Always consult your doctor, nurse or pharmacist before using any new medication.
Synedica Tirzepatide® 40mg Injection Pen Kit is available at selected pharmacies across Germany, and potentially free for German citizens who qualify under Gesetzliche Krankenversicherung.
Discover Synedica Tirzepatide 40 mg injection pen kit – a dual GIP/GLP-1 agonist designed to support weight management by reducing appetite and regulating blood sugar. Includes pen, disposable needles, and easy dosing instructions.









Reviews
There are no reviews yet.